Cargando…
Serum prolidase activity in benign joint hypermobility syndrome
BACKGROUND: Moderate joint laxity is widespread in many joints of the body, and this condition is considered to be caused by an abnormality in the collagen structure. This study was carried out to determine the serum prolidase activity in female patients with benign joint hypermobility syndrome (BJH...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995801/ https://www.ncbi.nlm.nih.gov/pubmed/24612543 http://dx.doi.org/10.1186/1471-2474-15-75 |
_version_ | 1782312939931303936 |
---|---|
author | Em, Serda Ucar, Demet Oktayoglu, Pelin Bozkurt, Mehtap Caglayan, Mehmet Yıldız, Ismail Evliyaoglu, Osman Nas, Kemal |
author_facet | Em, Serda Ucar, Demet Oktayoglu, Pelin Bozkurt, Mehtap Caglayan, Mehmet Yıldız, Ismail Evliyaoglu, Osman Nas, Kemal |
author_sort | Em, Serda |
collection | PubMed |
description | BACKGROUND: Moderate joint laxity is widespread in many joints of the body, and this condition is considered to be caused by an abnormality in the collagen structure. This study was carried out to determine the serum prolidase activity in female patients with benign joint hypermobility syndrome (BJHS), and to evaluate its correlation with their clinical features. METHODS: A total of 45 patients with BJHS and 40 healthy controls were included in the study. All of the patients with BJHS met the Beighton diagnostic criteria. All the patients and the control group underwent a comprehensive examination of the locomotor system and took the New York Posture Rating Test. The examination and test results were recorded. Serum prolidase activity was measured in both the groups. RESULTS: Prolidase activity was significantly lower in patients with BJHS (479.52 ± 126.50) compared to the healthy controls (555.97 ± 128.77) (p = 0.007). We found no correlation between serum prolidase activity and Beighton scores or New York rating test scores. On the other hand, mean prolidase activity was significantly lower in patients with pes planus or hyperlordosis compared to those without (p = 0.05, p = 0.03, respectively). We did not find such a correlation with the other clinical features. CONCLUSIONS: Significantly lower prolidase activity in patients with BJHS suggests that prolidase may affect the collagen metabolism and cause hyperlaxity. |
format | Online Article Text |
id | pubmed-3995801 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39958012014-04-23 Serum prolidase activity in benign joint hypermobility syndrome Em, Serda Ucar, Demet Oktayoglu, Pelin Bozkurt, Mehtap Caglayan, Mehmet Yıldız, Ismail Evliyaoglu, Osman Nas, Kemal BMC Musculoskelet Disord Research Article BACKGROUND: Moderate joint laxity is widespread in many joints of the body, and this condition is considered to be caused by an abnormality in the collagen structure. This study was carried out to determine the serum prolidase activity in female patients with benign joint hypermobility syndrome (BJHS), and to evaluate its correlation with their clinical features. METHODS: A total of 45 patients with BJHS and 40 healthy controls were included in the study. All of the patients with BJHS met the Beighton diagnostic criteria. All the patients and the control group underwent a comprehensive examination of the locomotor system and took the New York Posture Rating Test. The examination and test results were recorded. Serum prolidase activity was measured in both the groups. RESULTS: Prolidase activity was significantly lower in patients with BJHS (479.52 ± 126.50) compared to the healthy controls (555.97 ± 128.77) (p = 0.007). We found no correlation between serum prolidase activity and Beighton scores or New York rating test scores. On the other hand, mean prolidase activity was significantly lower in patients with pes planus or hyperlordosis compared to those without (p = 0.05, p = 0.03, respectively). We did not find such a correlation with the other clinical features. CONCLUSIONS: Significantly lower prolidase activity in patients with BJHS suggests that prolidase may affect the collagen metabolism and cause hyperlaxity. BioMed Central 2014-03-11 /pmc/articles/PMC3995801/ /pubmed/24612543 http://dx.doi.org/10.1186/1471-2474-15-75 Text en Copyright © 2014 Em et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Research Article Em, Serda Ucar, Demet Oktayoglu, Pelin Bozkurt, Mehtap Caglayan, Mehmet Yıldız, Ismail Evliyaoglu, Osman Nas, Kemal Serum prolidase activity in benign joint hypermobility syndrome |
title | Serum prolidase activity in benign joint hypermobility syndrome |
title_full | Serum prolidase activity in benign joint hypermobility syndrome |
title_fullStr | Serum prolidase activity in benign joint hypermobility syndrome |
title_full_unstemmed | Serum prolidase activity in benign joint hypermobility syndrome |
title_short | Serum prolidase activity in benign joint hypermobility syndrome |
title_sort | serum prolidase activity in benign joint hypermobility syndrome |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995801/ https://www.ncbi.nlm.nih.gov/pubmed/24612543 http://dx.doi.org/10.1186/1471-2474-15-75 |
work_keys_str_mv | AT emserda serumprolidaseactivityinbenignjointhypermobilitysyndrome AT ucardemet serumprolidaseactivityinbenignjointhypermobilitysyndrome AT oktayoglupelin serumprolidaseactivityinbenignjointhypermobilitysyndrome AT bozkurtmehtap serumprolidaseactivityinbenignjointhypermobilitysyndrome AT caglayanmehmet serumprolidaseactivityinbenignjointhypermobilitysyndrome AT yıldızismail serumprolidaseactivityinbenignjointhypermobilitysyndrome AT evliyaogluosman serumprolidaseactivityinbenignjointhypermobilitysyndrome AT naskemal serumprolidaseactivityinbenignjointhypermobilitysyndrome |